• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Cohen Ziffer Frenchman & McKenna

Policyholders’ Heaviest Hitters | Attorneys | New York

  • Team
  • News/Insights
  • Services
  • About
  • Careers
  • Offices
  • Team
  • News/Insights
  • Services
  • About
  • Careers
  • Offices

Stay Connected

News/Insights

Print PDF Email

Law360 reported, “Excess Insurer Owes Pfizer Coverage for Securities MDL’

September 1, 2020·News·less than a minute

On September 28, Delaware Superior Court Judge Paul R. Wallace ruled that Pfizer is entitled to coverage under its directors and officers policy with U.S. Specialty. The insurer will cover the “costs to defend and settle multidistrict litigation that accused the company of misleading investors about the alleged cardiovascular risks of its pain treatments Celebrex and Bextra.” Pfizer is represented by  Robin Cohen and Adam Ziffer. For more details, read the entire article here.

Primary Sidebar

Related People

  • Robin Cohen

  • Adam Ziffer

© 2023 Cohen Ziffer Frenchman & McKenna
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Contact Us